PRELYM Logo

PRELYM

About the Science

PRELYM Logo
About PRELYM

PRELYM (Prediction of Lysine Modification) is a computational tool that predicts which lysine residues and N-terminal amino groups in a protein will react with bioconjugation reagents, and in what order. By analyzing a protein's three-dimensional structure, PRELYM empowers researchers to design more effective protein modifications for therapeutic and biotechnology applications.

The Science behind PRELYM

Protein modification is fundamental to modern biotechnology, from developing longer-lasting therapeutics to creating enzyme-polymer conjugates with enhanced stability. However, predicting where and how proteins will be modified has historically relied on costly trial-and-error experiments.

PRELYM transforms this process by using structure-based prediction. The program analyzes several key molecular properties:

  • Surface Accessibility: How exposed each amino group is to potential modification
  • Chemical Environment: The pKa, local charge, and surrounding chemical interactions
  • Secondary Structure: Whether the residue is in a helix, strand, or coil
  • Quaternary Structure: How protein oligomerization affects modification patterns

By integrating these parameters through a validated decision tree algorithm, PRELYM classifies each reactive site as fast-reacting, slow-reacting, or non-reacting. This automated analysis takes just seconds and has been validated across multiple proteins including lysozyme, chymotrypsin, glucose oxidase, avidin, and therapeutic proteins like interferon-α 2a.

Origins in ATRP Research

PRELYM emerged from extensive research in Atom Transfer Radical Polymerization (ATRP)—a technique for growing polymers directly from protein surfaces. Unlike traditional PEGylation, ATRP offers precise control over polymer grafting density and location, enabling the creation of protein-polymer conjugates with dramatically improved stability, activity retention, and therapeutic properties.

Through systematic characterization of how ATRP initiators react with protein surfaces, the research team developed predictive rules based on tertiary structure analysis. PRELYM automates this knowledge, eliminating the laborious manual calculations previously required.

Broader Applications for the Community

Therapeutic Protein Engineering

Predict PEGylation sites in biologics to optimize reaction conditions and minimize heterogeneous product mixtures. PRELYM has successfully predicted modification patterns in FDA-approved therapeutics like PEG-interferon alpha-2a (PEGASYS).

Bioconjugation Design

Optimize coupling reactions for antibody-drug conjugates, enzyme immobilization, and biosensor development by understanding which sites will react first and which will remain protected.

Process Optimization

Reduce development timelines and material costs by computationally screening modification strategies before running experiments.

Rational Protein Design

Make informed decisions about site-specific modifications to preserve or enhance protein function while achieving desired pharmacological properties.

Educational Tool

Help students and researchers understand structure-function relationships in protein chemistry and the molecular basis of bioconjugation.

Explore our key publications

Tertiary structure-based prediction of how ATRP initiators react with proteins

S Carmali, H Murata, E Amemiya, K Matyjaszewski, AJ Russell

ACS Biomater. Sci. Eng. 3(9), 2086-2097 (2017)
Automated prediction of site and sequence of protein modification with ATRP initiators

A Patel, PN Smith, AJ Russell, S Carmali

PLoS ONE 17(9): e0274606 (2022)
Tailoring site specificity of bioconjugation using step-wise atom-transfer radical polymerization on proteins

S Carmali, H Murata, K Matyjaszewski, AJ Russell

Biomacromolecules 19(10), 4044-4051 (2018)
Moving protein PEGylation from an art to a data science

L Mao, AJ Russell, S Carmali

Bioconjugate Chemistry 33(9), 1643-1653 (2022)